A Phase III Clinical Trial to Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Vaccine (ORV) 116E (ROTAVAC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01305109
Recruitment Status : Unknown
Verified June 2012 by Bharat Biotech International Limited.
Recruitment status was:  Active, not recruiting
First Posted : February 28, 2011
Last Update Posted : June 12, 2012
Ministry of Science and Technology, India
Information provided by (Responsible Party):
Bharat Biotech International Limited